Semaphorin 3A (SEMA3A) represents a compelling biological target implicated in axonal guidance, tumor angiogenesis, immune regulation, and tissue fibrogenesis. However, targeting secreted semaphorins presents distinct off-target toxicity, mechanism redundancy, and translational clinical trial risks. This case study details how an R&D strategy team executed an evidence-based risk profiling...
Messages from Danielle
Pinterest
FEM Life Merch
How To: Create Page
How to: Engage
Womens Shelters
English
Spanish
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek